Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. High-dose vial. Lyophilized. COA included. It aids in weight loss by increasing energy expenditure, lowering appetite, and enhancing insulin sensitivity. Initial clinical trials have demonstrated encouraging outcomes, with notable decreases in mass and enhancements in glycemic management, placing Re... https://noblehghpharma.com/